demonstrated that targeted inhibition of MDSCs could improve the immune microenvironment of colon cancer, not only promoting the maturation of dendritic cells and tumor infiltration of CD8+ T cells, but also reducing the number of Tregs and M2 macrophages (112) (Figure 1D). The gene discussed is CD8A; the disease is colonic neoplasm.